137 related articles for article (PubMed ID: 23375231)
1. Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes.
Izumi Y; Yabe D; Taniguchi A; Fukushima M; Nakai Y; Hosokawa M; Okumura T; Nin K; Matsumoto K; Nishimura F; Nagasaka S; Seino Y
Diabetes Res Clin Pract; 2013 Feb; 99(2):145-50. PubMed ID: 23375231
[TBL] [Abstract][Full Text] [Related]
2. Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects.
Kurashina T; Nagasaka S; Watanabe N; Yabe D; Sugi N; Nin K; Hosokawa M; Nomura Y; Fukushima M; Nakai Y; Nishimura F; Taniguchi A
J Atheroscler Thromb; 2014; 21(7):730-8. PubMed ID: 24717758
[TBL] [Abstract][Full Text] [Related]
3. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients.
Kawasaki Y; Taniguchi A; Fukushima M; Nakai Y; Kuroe A; Ohya M; Nagasaka S; Yamada Y; Inagaki N; Seino Y
Horm Metab Res; 2005 Oct; 37(10):617-21. PubMed ID: 16278784
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults.
Lim CC; Teo BW; Tai ES; Lim SC; Chan CM; Sethi S; Wong TY; Sabanayagam C
PLoS One; 2015; 10(3):e0122009. PubMed ID: 25793395
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
[TBL] [Abstract][Full Text] [Related]
6. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease.
Stępień M; Stępień A; Wlazeł RN; Paradowski M; Banach M; Rysz M; Rysz J
Med Sci Monit; 2013 Nov; 19():1063-72. PubMed ID: 24280776
[TBL] [Abstract][Full Text] [Related]
7. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T
Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
[TBL] [Abstract][Full Text] [Related]
8. Circulating adipocytokines and chronic kidney disease.
Mills KT; Hamm LL; Alper AB; Miller C; Hudaihed A; Balamuthusamy S; Chen CS; Liu Y; Tarsia J; Rifai N; Kleinpeter M; He J; Chen J
PLoS One; 2013; 8(10):e76902. PubMed ID: 24116180
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender.
Lemoine S; Panaye M; Pelletier C; Bon C; Juillard L; Dubourg L; Guebre-Egziabher F
Am J Nephrol; 2016; 44(1):63-70. PubMed ID: 27400282
[TBL] [Abstract][Full Text] [Related]
10. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
[TBL] [Abstract][Full Text] [Related]
11. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
12. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
13. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population.
Tsuruya K; Yoshida H; Nagata M; Kitazono T; Hirakata H; Iseki K; Moriyama T; Yamagata K; Yoshida H; Fujimoto S; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
Atherosclerosis; 2014 Mar; 233(1):260-7. PubMed ID: 24529154
[TBL] [Abstract][Full Text] [Related]
14. High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease.
Huang WH; Chen CY; Lin JL; Lin-Tan DT; Hsu CW; Yen TH
Medicine (Baltimore); 2014 Aug; 93(7):e41. PubMed ID: 25101985
[TBL] [Abstract][Full Text] [Related]
15. Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study.
Yan P; Xu Y; Miao Y; Bai X; Wu Y; Tang Q; Zhang Z; Yang J; Wan Q
Acta Diabetol; 2021 Dec; 58(12):1615-1625. PubMed ID: 34181081
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
17. Serum Uric Acid and Risk of CKD in Type 2 Diabetes.
De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Feig D; Johnson RJ; Pontremoli R;
Clin J Am Soc Nephrol; 2015 Nov; 10(11):1921-9. PubMed ID: 26342044
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
[TBL] [Abstract][Full Text] [Related]
19. Effect of weight loss on the estimated glomerular filtration rates of obese patients at risk of chronic kidney disease: the RIGOR-TMU study.
Lin YC; Lai YJ; Lin YC; Peng CC; Chen KC; Chuang MT; Wu MS; Chang TH
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):756-766. PubMed ID: 30938491
[TBL] [Abstract][Full Text] [Related]
20. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
